CBDD Stock Overview
CBD of Denver Inc. se dedica a desarrollar y comercializar productos de cannabidiol (CBD).
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CBD of Denver Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.002 |
| 52 Week High | US$0.002 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 300.00% |
| 3 Month Change | 166.67% |
| 1 Year Change | 400.00% |
| 3 Year Change | -88.34% |
| 5 Year Change | 150.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBDD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 185.7% | -1.2% | -0.7% |
| 1Y | 400.0% | 15.8% | 25.9% |
Rentabilidad frente al sector: CBDD superó al sector US Pharmaceuticals , que obtuvo un rendimiento del 25% el año pasado.
Rentabilidad vs. Mercado: CBDD superó al mercado US, que obtuvo un rendimiento del 31.1% el año pasado.
Price Volatility
| CBDD volatility | |
|---|---|
| CBDD Average Weekly Movement | 36.8% |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CBDDha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: CBDD(35%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de los valores de US.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Paul Gurney | https://www.cbdofdenver.com |
CBD of Denver Inc. se dedica a desarrollar y comercializar productos de cannabidiol (CBD). Se dedica a la investigación, el desarrollo y la distribución de productos premium de extracto de cáñamo. La compañía era conocida anteriormente como Verde Media Group, Inc. y cambió su nombre a CBD of Denver Inc. en 2018.
CBD of Denver Inc. Fundamentals Summary
| CBDD fundamental statistics | |
|---|---|
| Market cap | US$9.35m |
| Earnings (TTM) | -US$503.32k |
| Revenue (TTM) | US$42.50k |
0.0x
P/S Ratio0.0x
P/E RatioIs CBDD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBDD income statement (TTM) | |
|---|---|
| Revenue | US$42.50k |
| Cost of Revenue | US$31.00k |
| Gross Profit | US$11.50k |
| Other Expenses | US$514.82k |
| Earnings | -US$503.32k |
Last Reported Earnings
Dec 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CBDD perform over the long term?
See historical performance and comparison